vendredi 21 avril 2017

FDA approves 2nd near-copy of Remicade for immune disorders

Federal regulators have approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders

from ABC News: Health http://ift.tt/2p4JkeM
via HEALTH

Aucun commentaire:

Enregistrer un commentaire